thiotepa has been researched along with Cancer of the Fallopian Tube in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Excerpt | Relevance | Reference |
---|---|---|
"Thiotepa (45 mg) was instilled into the chest cavity and medroxyprogesterone (100 mg tid) and melphalan (6 mg/d for 4 days over 6 weeks) were given." | 1.26 | Primary carcinoma of the fallopian tube. ( Kadziora, MB; Srinivasan, R, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kadziora, MB | 1 |
Srinivasan, R | 1 |
1 other study available for thiotepa and Cancer of the Fallopian Tube
Article | Year |
---|---|
Primary carcinoma of the fallopian tube.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Hu | 1981 |